Belite Bio Inc (BLTE) Stock Price, Quote, News & History

BLTENASDAQ
$193.61
22.5213.16%
At close: Sep 4, 5:00 PM EST
$193.61
N/A
After Hours: 4:00 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
-
Free Cash Flow (TTM)
-
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-

Analyst Trends and Forecast

2
Apr
2
May
1
Jun
3
Aug
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$6.41B
PE Ratio (TTM)
-
PE Ratio (FWD)
72.99
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
8.89
Earnings Yield % (TTM)
-1.60%
Earnings Yield % (FWD)
1.37%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$19.28

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
-
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$172.77
Close
$193.61
Volume / Avg.
735.50K / 189.76K
Day Range
$172.77 - $193.88
52 Wk Range
63.51 - 200.00
Market Cap
$7.26B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
73
Short Interest
5.59%
Days to Cover
5.84

About

Sector
Health Care
Industry
Pharmaceuticals
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Belite Bio (BLTE) stock?

A

You can purchase shares of Belite Bio (NASDAQ:BLTE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Belite Bio (BLTE) competitors?

Q

What is the forecast, or price target, for Belite Bio (BLTE) stock?

A

Belite Bio has a consensus price target of $191.67.

Q

What is the current price for Belite Bio (BLTE)?

A

The stock price for Belite Bio (NASDAQ: BLTE) is $193.61 last updated September 4, 2026 at 4:00 PM EDT.

Q

Does Belite Bio (BLTE) pay a dividend?

A

There are no upcoming dividends for Belite Bio.

Q

When is Belite Bio (NASDAQ:BLTE) reporting earnings?

A

Belite Bio does not have any upcoming earnings scheduled.

Q

Is Belite Bio (BLTE) going to split?

A

There is no upcoming split for Belite Bio.

Q

What sector and industry does Belite Bio (BLTE) operate in?

A

Belite Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.